Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAsian Institute of Gastroenterology, India

About this trial

Study objectives:

Primary objective:

1.To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm.

Secondary objectives:

To evaluate:

1. En bloc resection rate 2. Immediate and delayed adverse events 3. Procedure time 4. Histologic quality of resection (deep and lateral margins) 5. Residual disease at resection scar on surveillance endoscopy oMetachronous gastric NETs during follow-up

Eligibility criteria

Qualifiers

Age ≥18 years

Fit for endoscopic therapy and sedation

Written informed consent

Disqualifiers

Endoscopically visible gastric neuroendocrine tumor

Size 5-9 mm (endoscopic estimation)

Clinical and/or histologic features consistent with type I gastric NET

No endoscopic features suggestive of deep invasion

Trial design

Treatments tested in this trial

  • Endoscopic mucosal resection under water

Treatment groups

60 Participants
are divided into 1 treatment group